63 related articles for article (PubMed ID: 1966864)
1. Atrial natriuretic peptides inhibit protein kinase C activation in rat aortic smooth muscle.
Sauro MD; Fitzpatrick DF
Pept Res; 1990; 3(3):138-41. PubMed ID: 1966864
[TBL] [Abstract][Full Text] [Related]
2. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
Sauro MD; Thomas B
J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
[TBL] [Abstract][Full Text] [Related]
3. [Regulation of atrial natriuretic peptide receptor in cultured aortic vascular smooth muscle cells from stroke-prone spontaneously hypertensive and Wistar-Kyoto rats].
Liao YB; Zhang Q; Ding JF
Sheng Li Xue Bao; 1991 Aug; 43(4):368-75. PubMed ID: 1661442
[TBL] [Abstract][Full Text] [Related]
4. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein.
Saha S; Li Y; Lappas G; Anand-Srivastava MB
J Mol Cell Cardiol; 2008 Feb; 44(2):336-44. PubMed ID: 18162186
[TBL] [Abstract][Full Text] [Related]
5. Atrial peptides inhibit protein kinase C-mediated contraction in rat aorta.
Sauro MD; Fitzpatrick DF
Eur J Pharmacol; 1990 May; 180(2-3):373-6. PubMed ID: 2142097
[TBL] [Abstract][Full Text] [Related]
6. Activation of guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase in rat vas deferens and distal colon is not accompanied by inhibition of contraction.
Patel AI; Hennan JK; Diamond J
J Pharmacol Exp Ther; 1997 Nov; 283(2):894-900. PubMed ID: 9353411
[TBL] [Abstract][Full Text] [Related]
7. Regulation of contractile activity in vascular smooth muscle by protein kinases.
Silver PJ
Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
[TBL] [Abstract][Full Text] [Related]
8. Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase.
Light DB; Corbin JD; Stanton BA
Nature; 1990 Mar; 344(6264):336-9. PubMed ID: 1690355
[TBL] [Abstract][Full Text] [Related]
9. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
10. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
Cahill PA; Hassid A
J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
[TBL] [Abstract][Full Text] [Related]
12. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of hepatocyte protection against hypoxic injury by atrial natriuretic peptide.
Carini R; De Cesaris MG; Splendore R; Domenicotti C; Nitti MP; Pronzato MA; Albano E
Hepatology; 2003 Feb; 37(2):277-85. PubMed ID: 12540777
[TBL] [Abstract][Full Text] [Related]
14. Role of cyclic AMP protein kinase in decreased arterial cyclic AMP responsiveness in hypertension.
Silver PJ; Michalak RJ; Kocmund SM
J Pharmacol Exp Ther; 1985 Mar; 232(3):595-601. PubMed ID: 2983064
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol- and phosphatidylcholine-dependent phospholipases C are involved in the mechanism of action of atrial natriuretic factor in cultured rat aortic smooth muscle cells.
Zannetti A; Luly P; Musanti R; Baldini PM
J Cell Physiol; 1997 Mar; 170(3):272-8. PubMed ID: 9066784
[TBL] [Abstract][Full Text] [Related]
16. An activator of protein kinase C (phorbol dibutyrate) attenuates atrial-natriuretic-factor-stimulated cyclic GMP accumulation in smooth-muscle cells.
Nambi P; Whitman M; Aiyar N; Stassen F; Crooke ST
Biochem J; 1987 Jun; 244(2):481-4. PubMed ID: 2822009
[TBL] [Abstract][Full Text] [Related]
17. Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle.
Kanashiro CA; Khalil RA
Am J Physiol Cell Physiol; 2001 Jan; 280(1):C34-45. PubMed ID: 11121374
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic Ca2+ regulation attenuates ANP-induced cGMP response in vascular smooth muscle cells of the SHR.
Nakamura M; Nakamura A; Hatori N; Fine BP; Aviv A
Am J Hypertens; 1989 Feb; 2(2 Pt 1):111-3. PubMed ID: 2537090
[TBL] [Abstract][Full Text] [Related]
19. Vascular protein kinase C in Wistar-Kyoto and spontaneously hypertensive rats.
Silver PJ; Cumiskey WR; Harris AL
Eur J Pharmacol; 1992 Mar; 212(2-3):143-9. PubMed ID: 1601061
[TBL] [Abstract][Full Text] [Related]
20. Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats.
Russo R; Vecchione C; Cosentino F; Natale A; Mele AF; Muscolo M; Savoia C; Ganten D; Rubattu S; Volpe M
J Hypertens; 1998 Feb; 16(2):151-6. PubMed ID: 9535141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
